Actionable news
0
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

Amgen (AMGN) Stock Down Ahead of Q2 Earnings Report

NEW YORK (TheStreet) -- Shares of Amgen (AMGN) are sliding 0.28% to $165.20 this afternoon as the company prepares to report 2016 second quarter earnings on Wednesday, July 27 after the market close.

Wall Street is looking for earnings of $2.74 per share and revenue of $5.58 billion.

For the 2015 second quarter, the company reported earnings of $2.57 per share and revenue of $5.37 billion.

The company recently won a major copycat drug battle against rival Novartis (NVS) for Amgen's white blood cell-booster Neulasta...


More